Estimation of tenofovir's population pharmacokinetic parameters without reliable dosing histories and application to tracing dosing history using simulation strategies-Reference-Cited by-同舟云学术

Estimation of tenofovir's population pharmacokinetic parameters without reliable dosing histories and application to tracing dosing history using simulation strategies

Published:2013-11-30 Issue:2 Volume:54 Page:150-160
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Chaturvedula Ayyappa¹,Fossler Michael J.²,Hendrix Craig W.³

Affiliation:

1. Departments of Pharmacy Practice & Pharmaceutical Sciences; Mercer University College of Pharmacy; Atlanta GA USA

2. Clinical Pharmacology Modeling and Simulation; GlaxoSmithKline; King of Prussia PA USA

3. School of Medicine; Johns Hopkins University; Baltimore MD USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jcph.221/fullpdf

Reference36 articles.

1. Tenofovir disoproxil fumarate: clinical pharmacology and pharmacokinetics;Kearney;Clin Pharmacokinet.,2004

2. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men;Grant;N Engl J Med.,2010

3. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women;Baeten;N Engl J Med.,2012

4. Preexposure prophylaxis for HIV infection among African women;Van Damme;N Engl J Med.,2012

5. Marrazzo JM Ramjee G Nair G

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A multicompartment population PK model to predict tenofovir and emtricitabine mucosal tissue concentrations for HIV prevention;CPT: Pharmacometrics & Systems Pharmacology;2023-10-09

2. Clinical trial simulation to evaluate tenofovir disoproxil fumarate/emtricitabine HIV pre-exposure prophylaxis dosing during pregnancy;Frontiers in Reproductive Health;2023-09-27

3. Combining information to estimate adherence in studies of pre‐exposure prophylaxis for HIV prevention: Application to HPTN 067;Statistics in Medicine;2022-01-25

4. Tenofovir Plasma Concentration from Preexposure Prophylaxis at the Time of Potential HIV Exposure: a Population Pharmacokinetic Modeling and Simulation Study Involving Serodiscordant Couples in East Africa;Antimicrobial Agents and Chemotherapy;2019-08

Patterns of non-adherence to oral antiretroviral medication: frequencies of consecutively missed doses

;Patient Preference and Adherence;2019-03